Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

News

Zepbound beats Wegovy for weight loss

Digest more
This drug led to 50% more weight loss than Wegovy in head-to-head study
While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors find concerning. In trials of Wegovy, up to 40% of weight loss was from a decrease in lean or fat-free mass, rather than excess fat. In addition, quitting the drugs can mean adding back the pounds.

Continue reading

 · 4h
HealthLeaders Media · 6h
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
 · 1d · on MSN
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
1don MSN
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...
STAT
5d
Compounders lose legal battle with FDA over removal of Eli Lilly’s weight loss drug from a shortage list
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
1don MSN
Which Weight-Loss Drug Works the Best?
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
TCTMD
2h
App-Based Support Aids Weight Loss With Semaglutide, Studies Show
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy